SCHEMBL28111576

SCHEMBL28111576

Cc1nc(Nc2nc(NCc3ccc(S(C)(=O)=O)cc3)cc(-c3cccnc3)n2)sc1C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 2/20 0.50
VCP P55072 6/20 0.46
GPR39 O43194 1/20 0.46
PTGS2 P35354 3/20 0.40
PTGS1 P23219 1/20 0.40
MAPK8 P45983 1/20 0.40
MAPK9 P45984 1/20 0.40
MAPK10 P53779 1/20 0.40
MAPK14 Q16539 1/20 0.40
HDAC1 Q13547 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
ALDH1A1 P00352 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
HSD17B10 Q99714 1/20 0.39
CLK4 Q9HAZ1 1/20 0.39
NAMPT P43490 1/20 0.39
PDE3B Q13370 1/20 0.39
PDE3A Q14432 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL290571 0.91 PDE5A (0.63) PDE5AGPR39ALDH1A1PDE3BPDE3A
SCHEMBL28798098 0.85 PDE5A (0.49) PDE5AVCPGPR39PTGS2PTGS1
SCHEMBL291267 0.83 PDE5A (0.56) PDE5AGPR39PTGS2ALDH1A1PDE3B
SCHEMBL20560172 0.78 PDE5A (0.58) PDE5AVCPPDE3BPDE3A
SCHEMBL290492 0.77 PDE5A (0.59) PDE5AALDH1A1PDE3BPDE3A
SCHEMBL20559835 0.76 PDE5A (0.59) PDE5AGPR39ALDH1A1PDE3BPDE3A
SCHEMBL4002542 0.76 PDE3B (0.49) PDE5AGPR39MAPK8MAPK9ALDH1A1
SCHEMBL291527 0.76 PDE5A (0.81) PDE5AVCPPDE3BPDE3A
SCHEMBL291368 0.76 PDE5A (0.62) PDE5ATDP1ALDH1A1HSD17B10PDE3B
SCHEMBL291579 0.76 PDE5A (0.62) PDE5AALDH1A1PDE3BPDE3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106038567-A Treatment of addiction and impulse-control disorders using pde7 inhibitors 奥默罗斯公司 2016-10-26 CN disclosed